Hindman James M. 4
4 · Urovant Sciences Ltd. · Filed Jun 1, 2020
Insider Transaction Report
Form 4
Hindman James M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-01+61,000→ 61,000 totalExercise: $10.53Exp: 2030-06-01→ Common Shares (61,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest and become exercisable in three equal annual installments beginning on June 1, 2021, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.